Diagnostic value of combination of cranial MRI, serum homocysteine and procalcitonin for hyperbilirubinemia complicated with brain injury in neonates

Chang,Na; Wang,Guangbin

doi:10.3892/etm.2020.9179

Diagnostic value of combination of cranial MRI, serum homocysteine and procalcitonin for hyperbilirubinemia complicated with brain injury in neonates

Authors:
- Na Chang
- Guangbin Wang
View Affiliations

Affiliations: Department of Medical Imaging, Shandong University, Jinan, Shandong 250012, P.R. China, Shandong Medical Imaging Research Institute, Shandong University, Jinan, Shandong 250021, P.R. China
Published online on: September 3, 2020 https://doi.org/10.3892/etm.2020.9179
Article Number: 51
Copyright: © Chang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to explore the diagnostic value of the combination of cranial magnetic resonance imaging (MRI), serum homocysteine (HCY) and procalcitonin (PCT) for hyperbilirubinemia complicated with brain injury in neonates. One hundred and forty‑nine children with hyperbilirubinemia admitted to Shandong Medical Imaging Research Institute from January 2014 to April 2016 were collected as research subjects, and were divided into a brain injury group (n=67) and a non‑brain injury group (n=82) according to whether children suffered from brain injury. PCT levels were detected by electrochemiluminescence (ECL), and HCY levels by enzymatic cycling assay (ECA). The combination of cranial MRI, HCY and PCT was used to diagnose hyperbilirubinemia complicated with brain injury in neonates. The concentrations of HCY and PCT in the brain injury group were significantly higher than those in the non‑brain injury group (P<0.001). According to the MRI examination results, the patients were divided into an MRI normal group and an MRI abnormal group. In the brain injury group, the serum HCY and PCT levels of the MRI abnormal group were significantly higher than those of the MRI normal group, with a statistically significant difference (P<0.05). In the non‑brain injury group, the serum HCY and PCT levels of the MRI abnormal group were significantly higher than those of the MRI normal group, with a statistically significant difference (P<0.05). The sensitivity of the combined detection was significantly higher than that of single detection (P<0.05); the specificity was significantly higher than that of HCY detection (P<0.05), and the accuracy was significantly higher than that of MRI and HCY single detection (P<0.05). In conclusion, the combination of cranial MRI, HCY and PCT, which has a high diagnostic value for hyperbilirubinemia complicated with brain injury in neonates, is conducive to the early diagnosis and timely treatment of the disease and the reduction of sequelae.

View Figures

View References

1	Zheng J, Wei C, Zhao M and Zhao D: Phototherapy is associated with the decrease in serum globulin levels in neonatal hyperbilirubinemia. Biomed Rep. 10:63–69. 2018.PubMed/NCBI View Article : Google Scholar
2	Yu ZB, Han SP and Chen C: Bilirubin nomograms for identification of neonatal hyperbilirubinemia in healthy term and late-preterm infants: A systematic review and meta-analysis. World J Pediatr. 10:211–218. 2014.PubMed/NCBI View Article : Google Scholar
3	Petersen JP, Henriksen TB, Hollegaard MV, Vandborg PK, Hougaard DM, Thorlacius-Ussing O and Ebbesen F: Extreme neonatal hyperbilirubinemia and a specific genotype: A population-based case-control study. Pediatrics. 134:510–515. 2014.PubMed/NCBI View Article : Google Scholar
4	Kuzniewicz MW, Wickremasinghe AC, Wu YW, McCulloch CE, Walsh EM, Wi S and Newman TB: Incidence, etiology, and outcomes of hazardous hyperbilirubinemia in newborns. Pediatrics. 134:504–509. 2014.PubMed/NCBI View Article : Google Scholar
5	Koziol LF, Budding DE and Chidekel D: Hyperbilirubinemia: Subcortical mechanisms of cognitive and behavioral dysfunction. Pediatr Neurol. 48:3–13. 2013.PubMed/NCBI View Article : Google Scholar
6	Smitherman H, Stark AR and Bhutani VK: Early recognition of neonatal hyperbilirubinemia and its emergent management. Semin Fetal Neonatal Med. 11:214–225. 2006.PubMed/NCBI View Article : Google Scholar
7	Maisels MJ: Neonatl jaundice. Pediatr Rev. 27:443–454. 2006.PubMed/NCBI View Article : Google Scholar
8	Qian-Qian F, Shao-Hua W and Department P: The clinical progress in early diagnosis of bilirubin encephalopathy. Med Recap. 20:1186–1189. 2014.
9	Shi-Xin FU, Kai-Zhong Z, Yan B, et al: Imaging features and clinical outcome of MRI and MRS in children with bilirubin encephalopathy. Chin J CT MRI. 16:11–13. 2018.
10	Monsef A and Eghbalian F: Evaluation of diagnostic value of procalcitonin as a marker of neonatal bacterial infections. Iran J Pediatr. 22:314–318. 2012.PubMed/NCBI
11	Czyzewska M, Lachowska M and Gajewska E: Evaluation of diagnostic value of procalcitonin (PCT) as a marker of congenital infection in newborns. Przegl Lek. 59 (Suppl 1):S46–S49. 2002.PubMed/NCBI(In Polish).
12	Kawezymksi P and Piotrowski A: Procalcitonin and C-reactive protein as a markers of neonatal sepsis. Cinekol Pol. 75:439–444. 2004.PubMed/NCBI(In Polish).
13	Zahedpasha Y, Ahmadpour M, Hajiahmadi M and Haghshenas M: Procalcitonin as a marker of neonatal sepsis. Iran J Pediatr. 19:117–122. 2009.
14	Weidong HE and Laboratory DO: Application value of immature granulocyte, D-dimer, FDP and PCT detection in neonatal hyperbilirubinemia. China Health Stand Manage. 7:145–147. 2016.
15	Bo G, Feng L, Guoxin X, et al: Clinical significance of procalcitonin, C-reactive protein and myocardial enzymes determination in patients with neonatal hyperbilirubinemia. Int J Lab Med. 35:2441–2443. 2014.
16	Joshi MB, Baipadithaya G, Balakrishnan A, Hegde M, Vohra M, Ahamed R, Nagri SK, Ramachandra L and Satyamoorthy K: Elevated homocysteine levels in type 2 diabetes induce constitutive neutrophil extracellular traps. Sci Rep. 6(36362)2016.PubMed/NCBI View Article : Google Scholar
17	Mangge H, Becker K, Fuchs D and Gostner JM: Antioxidants, inflammation and cardiovascular disease. World J Cardiol. 6:462–477. 2014.PubMed/NCBI View Article : Google Scholar
18	Curro M, Gugliandolo A, Gangemi C, Risitano R, Ientile R and Caccamo D: Toxic effects of mildly elevated homocysteine concentrations in neuronal-like cells. Neurochem Res. 39:1485–1495. 2014.PubMed/NCBI View Article : Google Scholar
19	Wu F, Yang H and Liu B: Association between homocysteine and arterial stiffness in women with a history of preeclampsia. J Vasc Res. 56:152–159. 2019.PubMed/NCBI View Article : Google Scholar
20	Dan-Ni YE, Ling-Qing GE and Sheng-Lin YU: Diagnostic significance of brainstem auditory evoked potential combined with MRI in early neonatalbilirubin encephalopathy. Chin J Child Health Care. 25:737–740. 2017.
21	Yan B, Kaizhong Z, Qian Z, et al: Diagnostic performance compared of MRI and MRS in neonatal acute bilirubin encephalopathy. Chin Imaging J Integr Tradit West Med, 2017.
22	Sgro M, Campbell D, Barozzino T and Shah V: Acute neurological findings in a national cohort of neonates with severe neonatal hyperbilirubinemia. J Perinatol. 31:392–396. 2011.PubMed/NCBI View Article : Google Scholar
23	Iskander I, Gamaleldin R, El Houchi S, El Shenawy A, Seoud I, El Gharbawi N, Abou-Youssef H, Aravkin A and Wennberg RP: Serum bilirubin and bilirubin/albumin ratio as predictors of bilirubin encephalopathy. Pediatrics. 134:e1330–e1339. 2014.PubMed/NCBI View Article : Google Scholar
24	Wisnowski JL, Panigrahy A, Painter MJ and Watchko JF: Magnetic resonance imaging of bilirubin encephalopathy: current limitations and future promise. Semin Perinatol. 38:422–428. 2014.PubMed/NCBI View Article : Google Scholar
25	Xiao-Li M, Lei Z, Xiao-Hu W, et al: Analysis of MRI signal characteristics of neonatal severe hyperbilirubinemia. Chin J Magn Reson Imaging. 9:768–772. 2018.
26	Lin N, Qin S, Luo S, Cui S, Huang G and Zhang X: Homocysteine induces cytotoxicity and proliferation inhibition in neural stem cells via DNA methylation in vitro. FEBS J. 281:2088–2096. 2014.PubMed/NCBI View Article : Google Scholar
27	Peschanski N, Chenevier-Gobeaux C, Mzabi L, Lucas R, Ouahabi S, Aquilina V, Brunel V, Lefevre G and Ray P: Prognostic value of PCT in septic emergency patients. Ann Intensive Care. 6(47)2016.PubMed/NCBI View Article : Google Scholar
28	Velissaris D, Pintea M, Pantzaris N, Spatha E, Karamouzos V, Pierrakos C and Karanikolas M: The role of procalcitonin in the diagnosis of meningitis: A literature review. J Clin Med. 7(148)2018.PubMed/NCBI View Article : Google Scholar
29	La'ulu SL, Rawlins ML, Pfeiffer CM, Zhang M and Roberts WL: Performance characteristics of six homocysteine assays. Am J Clin Pathol. 130:969–975. 2008.PubMed/NCBI View Article : Google Scholar
30	Moretti R and Caruso P: The controversial role of homocysteine in neurology: From labs to clinical practice. Int J Mol Sci. 20(231)2019.PubMed/NCBI View Article : Google Scholar
31	Sukla KK, Tiwari PK, Kumar A and Raman R: Low birthweight (LBW) and neonatal hyperbilirubinemia (NNH) in an Indian cohort: Association of homocysteine, its metabolic pathway genes and micronutrients as risk factors. PLoS One. 8(e71587)2013.PubMed/NCBI View Article : Google Scholar
32	Zhang HY, Qiao LX, Zhu WY and Wang Hua: Diagnostic value of NBNA score combined head MRI in the neonates with severe hyperbilirubinemia for brain injury. Chin J Child Health Care. 25:164–166. 2017.
33	Yanming GE, Yaowu LI and Qinyan XU: The study on the correlation between features of magnetic resonance imaging and serum index about hyperbilirubinemia of the neonates. J Clin Radiol. 34:1468–1471. 2015.
34	Chen LJ, Wang XM, Wan YZ, Li WH, Jia YG, Yun CH and Chen TH: Superconducting MRI signal intensity in pallidum in neonatal hyperbilirubinemia. Chin J Rehabil Theory Pract. 22:838–840. 2016.(In Chinese).
35	Li XH, Zhang J, Zheng H, et al: Clinical significance of cerebrospinal fluid bilirubin and craniocerebral magnetic resonance imaging measurements in newborns with bilirubin encephalopathy. Pract Clin Med. 4:76–79. 2014.
36	Wang T, Sun ZW, Shao LQ, Xu XB, Liu Y, Qin M, Weng X and Zhang YX: Diagnostic values of serum levels of homocysteine and uric acid for predicting vascular mild cognitive impairment in patients with cerebral small vessel disease. Med Sci Monit. 23:2217–2225. 2017.PubMed/NCBI View Article : Google Scholar
37	Wei W, Jinyue C, Qing Z, Chunxiao F, Min L and Mingfen L: Early diagnosis value of procalcitonin in severe brain damage combined with pulmonary infection. Int J Lab Med. 2934–2936. 2015.(In Chinese).
38	Ai-Hua F, Shu-Ming P, Ming L, et al: Value of procalcitonin to the prediction of multiple organ dysfunction syndrome in patients with brain injury. J Chin Pract Diagn Ther, 2011.
39	Li Y: Application of MRI combined with caspase-1 and IL-6 in the diagnosis of white matter damage in premature infants. Lab Med Clin. 14:2211–2213. 2017.